When should the Carpenter‑Coustan criteria be used versus the National Diabetes Data Group (NDDG) criteria for diagnosing gestational diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Use Carpenter-Coustan vs NDDG Criteria

Use Carpenter-Coustan criteria exclusively for diagnosing gestational diabetes mellitus (GDM) in the two-step screening approach—the NDDG criteria are outdated and should not be used in clinical practice. 1, 2

Current Guideline Recommendations

The most recent ADA Standards of Care (2025) explicitly recommend only the Carpenter-Coustan criteria when using the two-step strategy for GDM diagnosis 2. The guidelines present two acceptable diagnostic strategies:

One-Step Strategy (IADPSG Criteria)

  • Perform 75-g OGTT at 24-28 weeks
  • Diagnose GDM if any one value meets or exceeds:
    • Fasting: 92 mg/dL
    • 1-hour: 180 mg/dL
    • 2-hour: 153 mg/dL

Two-Step Strategy (Carpenter-Coustan Only)

  • Step 1: 50-g glucose load test (GLT) at 24-28 weeks
    • Proceed to Step 2 if ≥130,135, or 140 mg/dL at 1 hour
  • Step 2: 100-g OGTT with Carpenter-Coustan thresholds
    • Diagnose GDM if at least two values meet or exceed:
      • Fasting: 95 mg/dL
      • 1-hour: 180 mg/dL
      • 2-hour: 155 mg/dL
      • 3-hour: 140 mg/dL

2, 3, 4

Why Carpenter-Coustan Supersedes NDDG

The Carpenter-Coustan criteria identify significantly more women at risk for adverse pregnancy outcomes compared to NDDG criteria. Research demonstrates that women diagnosed by Carpenter-Coustan but not by NDDG have:

  • 1.70-fold increased risk of preeclampsia 5
  • 1.44-fold increased risk of cesarean delivery 6
  • 4.47-fold increased risk of macrosomia (>4500g) 6
  • 2.24-fold increased risk of shoulder dystocia 6

The NDDG criteria use higher glucose thresholds (fasting 105 mg/dL vs 95 mg/dL; 2-hour 165 mg/dL vs 155 mg/dL), missing approximately 42-69% more women who would benefit from treatment 5, 6, 7. These "missed" women have the same long-term risk of developing type 2 diabetes as those diagnosed by NDDG criteria 7.

Clinical Decision Algorithm

For all pregnant women at 24-28 weeks gestation:

  1. Choose your institutional approach (one-step vs two-step)

    • One-step: Use IADPSG criteria (preferred by ADA for optimizing gestational outcomes) 2
    • Two-step: Use Carpenter-Coustan criteria exclusively
  2. Never use NDDG criteria in contemporary practice

    • Not mentioned in guidelines after 2015 1
    • Inferior sensitivity for detecting at-risk pregnancies 5, 6
    • No longer considered acceptable standard of care
  3. For high-risk populations, consider:

    • Lower GLT threshold (130 mg/dL) for Step 1 screening 2
    • ACOG notes that even one elevated value on 100-g OGTT can be used for diagnosis 2

Important Caveats

The one-step IADPSG approach diagnoses approximately twice as many women with GDM compared to the two-step Carpenter-Coustan approach (15-20% vs 5-8% prevalence) 4, 8. However, 80-90% of women diagnosed by IADPSG criteria can be managed with lifestyle modifications alone 9, 10.

Do not use either Carpenter-Coustan or NDDG criteria for early pregnancy screening (<24 weeks)—these were derived from data at 24-28 weeks gestation and are not validated for first-trimester use 4.

For women requiring treatment, glycemic targets remain consistent regardless of diagnostic criteria used:

  • Fasting <95 mg/dL
  • 1-hour postprandial <140 mg/dL OR
  • 2-hour postprandial <120 mg/dL

9, 10

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.